Open access
123
Views
9
CrossRef citations to date
0
Altmetric
Original Research
Real-life effectiveness of indacaterol–glycopyrronium after switching from tiotropium or salmeterol/fluticasone therapy in patients with symptomatic COPD: the POWER study
Alan Kaplan1 Family Physician Airways Group of Canada, University of Toronto, Toronto, ON, Canada, [email protected]Correspondence[email protected]
, Kenneth R Chapman2 Division of Respiratory Medicine, Department of Medicine, University of Toronto, Toronto, ON, Canada
, Syed M Anees3 Schulich School of Medicine & Dentistry – Western University, University of Windsor, ON, Canada
, Irvin Mayers4 Division of Pulmonary Medicine, Department of Medicine, University of Alberta, Edmonton, AB, Canada
, Driss Rochdi5 Novartis Pharmaceuticals Canada Inc., Montreal, QC, Canada
, Michel Djandji5 Novartis Pharmaceuticals Canada Inc., Montreal, QC, Canada
, David Préfontaine5 Novartis Pharmaceuticals Canada Inc., Montreal, QC, Canada
& Andrew McIvor6 Department of Medicine, McMaster University, Firestone Institute for Respiratory Health, Hamilton, ON, Canada
show all
Pages 249-260
|
Published online: 18 Jan 2019
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.